CIK 1720745
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2021-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Unclassified | 29.46% | 2 |
| Banks | 21.72% | 1 |
| Pharmaceuticals & Biotechnology | 19.29% | 1 |
| Health Care Equipment & Supplies | 16.32% | 2 |
| Software | 13.22% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | HDB | HDFC Bank Ltd | Financials | 21.72% |
| 2 | TAK | Takeda Pharmaceutical Co Ltd | Health Care | 19.29% |
| 3 | Ferguson Plc New | Unclassified | 15.61% | |
| 4 | PROF | Profound Medical Corp. | Health Care | 14.07% |
| 5 | WIX | WIX COM LTD | Unclassified | 13.85% |
| 6 | NICE | NICE Ltd. | Information Technology | 13.22% |
| 7 | RCEL | AVITA Medical, Inc. | Health Care | 2.25% |
5/7 names classified · sector 70.5% of weight · industry 70.5% · mkt cap 16.3%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 70.5% of the book is sector-classified (unclassified names shown, never dropped).
Only 0% of book weight classified — the grid is NOT representative of the whole book.
Classified: 0.0% of book weight (0/7 names) · unclassified 100.0%: HDB, TAK, , PROF, WIX, NICE, RCEL. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | HDBHDFC BANK LTD | 57,807 | $4M | 21.7% | TRIM −18% |
| 2 | TAKTAKEDA PHARMACEUTICAL CO LTD | 30,201 | $3M | 19.3% | TRIM −3% |
| 3 | Ferguson Plc New | 18,677 | $3M | 15.6% | TRIM −79% |
| 4 | PROFPROFOUND MED CORP | 255,292 | $2M | 14.1% | TRIM −75% |
| 5 | WIXWIX COM LTD | 21,643 | $2M | 13.8% | TRIM −64% |
| 6 | NICENICE LTD | 9,855 | $2M | 13.2% | TRIM −76% |
| 7 | RCELAVITA MEDICAL INC | 43,324 | $367,000 | 2.2% | TRIM −90% |
Where this firm's principals came from and which firms its alumni went on to found.
